A phase I/II study of temsirolimus and sunitinib in subjects with advanced renal cell carcinoma

Trial Profile

A phase I/II study of temsirolimus and sunitinib in subjects with advanced renal cell carcinoma

Discontinued
Phase of Trial: Phase I/II

Latest Information Update: 11 Oct 2007

At a glance

  • Drugs Sunitinib; Temsirolimus
  • Indications Renal cancer
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Wyeth
  • Most Recent Events

    • 11 Oct 2007 Status changed to discontinued - a decision was made not to trial a lower dose.
    • 17 Sep 2007 Status changed from in progress to completed.
    • 18 Jan 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top